|
× |
 |
Hydroxychloroquine-Induced QT Prolongation in a COVID-19–Positive Patient on Clozapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clozapine Withdrawal-Emergent Dystonias and Dyskinesias: A Case Series PDF |
$40.00 |
|
$40.00 |
|
× |
|
Behavioral Interventions for Antipsychotic Medication-Associated Obesity: A Randomized, Controlled Clinical Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prompt Use of Benzodiazepines for Anxiety Management in COVID-19-Positive Patients With Tracheostomy PDF |
$40.00 |
|
$40.00 |
|
× |
|
Abrupt Symptom Improvements in Antidepressant Clinical Trials: Transient Placebo Effects or Therapeutic Reality? PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Pilot Study of an Electronic, Adolescent Version of the Quick Inventory of Depressive Symptomatology PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Placebo-Controlled Trial of Cognitive-Behavioral Therapy and Clomipramine in Trichotillomania PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
|
